Sang Lee

Sang Lee builds frontier AI systems that decode human biology. As an entrepreneur at the intersection of artificial intelligence, biotechnology, and digital infrastructure, he works on transforming raw molecular signals—especially RNA—into predictive, actionable models for health, disease, and precision medicine at population scale. His ventures also extend into advanced capital-markets engineering, where he develops AI-driven financial systems and new architectures for digital asset infrastructure. He is widely recognized as a leading voice, having spoken at the United Nations, International CES, National Science Foundation, Brown University, Columbia University, and the Council on Foreign Relations. His work has reached audiences across the U.S., Greater China, South Korea, Indonesia, Luxembourg, Taiwan, and Ukraine. His companies and ideas have been featured in Forbes, CNBC, Fast Company, Entrepreneur Magazine, Crain’s, Huffington Post, and L’Express. He was named a GOOD 100 changemaker and selected as an “Under30CEO Entrepreneur to Watch” in New York City.